[
    "{\"step_by_step_thinking\": \"Tisagenlecleucel is a type of immunotherapy known as chimeric antigen receptor (CAR) T-cell therapy. It involves modifying a patient's own T cells to express a receptor that targets a specific protein on cancer cells. B-cell lymphoma is a type of cancer that affects B cells, so it is possible that Tisagenlecleucel could be effective for this type of lymphoma. To determine the effectiveness of Tisagenlecleucel for B-cell lymphoma, we need to review clinical trials and studies that have specifically evaluated its use in this context.\", \"answer_choice\": \"A. yes\"}"
]